DK103795C - Process for the preparation of vaccine and antigen preparations using a soluble alginate. - Google Patents

Process for the preparation of vaccine and antigen preparations using a soluble alginate.

Info

Publication number
DK103795C
DK103795C DK450062AA DK450062A DK103795C DK 103795 C DK103795 C DK 103795C DK 450062A A DK450062A A DK 450062AA DK 450062 A DK450062 A DK 450062A DK 103795 C DK103795 C DK 103795C
Authority
DK
Denmark
Prior art keywords
vaccine
preparation
antigen preparations
soluble alginate
alginate
Prior art date
Application number
DK450062AA
Other languages
Danish (da)
Original Assignee
Cons Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US150892A external-priority patent/US3075883A/en
Application filed by Cons Lab Inc filed Critical Cons Lab Inc
Application granted granted Critical
Publication of DK103795C publication Critical patent/DK103795C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK450062AA 1961-10-19 1962-10-18 Process for the preparation of vaccine and antigen preparations using a soluble alginate. DK103795C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB37504/61A GB950498A (en) 1961-10-19 1961-10-19 Vaccine or antigen compositions
US150892A US3075883A (en) 1961-11-08 1961-11-08 Novel parenteral vaccine antigen compositions and methods of making and using

Publications (1)

Publication Number Publication Date
DK103795C true DK103795C (en) 1966-02-21

Family

ID=26263468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK450062AA DK103795C (en) 1961-10-19 1962-10-18 Process for the preparation of vaccine and antigen preparations using a soluble alginate.

Country Status (7)

Country Link
BE (1) BE623825A (en)
CH (1) CH470184A (en)
DE (1) DE1170582B (en)
DK (1) DK103795C (en)
FR (2) FR3561M (en)
GB (1) GB950498A (en)
SE (1) SE328369B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114699364A (en) * 2022-03-29 2022-07-05 山东大学 Alginate injectable hydrogel and preparation method and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7901565L (en) * 1979-02-21 1980-08-22 Pharmacia Ab Means of Immunization

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114699364A (en) * 2022-03-29 2022-07-05 山东大学 Alginate injectable hydrogel and preparation method and application thereof

Also Published As

Publication number Publication date
SE328369B (en) 1970-09-14
DE1170582B (en) 1964-05-21
CH470184A (en) 1969-03-31
FR1505310A (en) 1967-12-15
BE623825A (en)
GB950498A (en) 1964-02-26
FR3561M (en) 1965-09-27

Similar Documents

Publication Publication Date Title
DK123976B (en) Process for the preparation of 1-amino-adamantane hydrochloride.
DK119079B (en) Process for the preparation of in vivo dispersible veterinary medicinal preparations.
DK104307C (en) Process for the preparation of a hexapeptide.
BE591268A (en) Polio vaccine.
FI40108C (en) Method for stabilizing labile antigenic viral preparations
DK103795C (en) Process for the preparation of vaccine and antigen preparations using a soluble alginate.
DK120637B (en) Process for the preparation of α- (3-indolyl) -alkane- or -alkene acids.
DK105490C (en) Process for the preparation of a staphylococcal antigen product in the form of immunogenic polysaccharide compounds.
DK112161B (en) Process for the preparation of a yeast preparation for pharmaceutical use.
NL139870B (en) PROCESS FOR THE PREPARATION OF INSECTICIDE PREPARATIONS.
DK101508C (en) Process for the preparation of injectable pollen-containing antigen preparations.
DK99169C (en) Process for the preparation of pharmaceutical sitosterin preparations.
DK104114C (en) Process for the preparation of 1-phenoxyphenylamino and 1-phenyl-thiophenylamino-4-hydroxyanthraquinone dyes.
DK105008C (en) Insecticide and process for the preparation of arylalkylphosphonothioates for use in the insecticide.
FI40401C (en) Method for the preparation of durable oral poliomyelitis virus preparations
CA631016A (en) Rubeola virus vaccine
CA643834A (en) Vaccine and process for its preparation
DK100701C (en) Method for preparing a mixed vaccine.
DK99701C (en) Process for the preparation of foot-and-mouth disease concentrate vaccines.
DK101633C (en) Process for the preparation of radioactive chromium preparations.
AU262763B2 (en) Vaccine and / or antigen composition for parenteral injection comprising a soluble alginate
CA614110A (en) Otologic preparations and the process for their preparation
CA636636A (en) Antigenic preparation and method of preparing the same
AU257182B2 (en) Stable oral anti-poliomyelitis vaccines and process for preparing them
CA541763A (en) Rabies vaccines and methods of preparing the same